Why Digital Health Startups Are Betting on Hearing Aids

In this episode of The Digital Health Podcast, Lucas and Luna explore a surprising new frontier in digital health: the hearing aid market. With the FDA's over-the-counter rule change now two years old, a wave of startups and tech giants are reimagining hearing aids as consumer wearables. Lucas breaks down how companies like Sony, Jabra, and startup Whisper are using smartphone-based tuning, AI-driven sound processing, and direct-to-consumer pricing to disrupt a market long dominated by a handful of legacy players. He explains the economics: traditional hearing aids cost $2,000 to $7,000 per pair, but OTC models are already under $1,000, with some startups targeting $500. Luna questions whether the sound quality and customization can match prescription devices. The hosts discuss a 2025 JAMA study showing that OTC hearing aids perform comparably to prescription ones for mild to moderate hearing loss. They also look at the broader health implications: untreated hearing loss is linked to cognitive decline and dementia. Lucas argues that the OTC shift isn't just about cheaper hardware—it's about embedding hearing health into the Apple Watch and Android ecosystem, turning every smartphone into a potential hearing diagnostic tool. The episode closes with a look at what this means for public health and the legacy industry's response. #HearingAids #DigitalHealth #OTC #FDA #JAMA #Whisper #Sony #Jabra #CognitiveDecline #Dementia #Wearables #Audiology #Startups #Business #Technology #FexingoBusiness #BusinessPodcast #HealthTech Keep every episode free: buymeacoffee.com/fexingo